Search for: "*u.s. v. Noonan"
Results 161 - 180
of 482
Sorted by Relevance
|
Sort by Date
14 Jan 2024, 9:29 pm
The case arose in Pacific Bioscience's IPR challenges to different combinations of claims* of U.S. [read post]
12 Oct 2009, 9:59 pm
These patents were: U.S. [read post]
11 Nov 2018, 9:59 pm
Noonan -- On Friday, the Federal Circuit handed down its decision in Arista Networks, Inc. v. [read post]
3 May 2020, 9:10 pm
The appeal arose over U.S. [read post]
28 Nov 2016, 9:59 pm
The case involved Roxane's U.S. [read post]
29 Sep 2020, 9:50 pm
Biogen asserted U.S. [read post]
28 Aug 2014, 9:29 pm
Noonan -- In the first of a pair of decisions issued last Friday, Ferring B.V. v. [read post]
10 Apr 2016, 9:59 pm
Noonan -- The Federal Circuit affirmed the latest invalidation of genetic diagnostic claims last week, in Genetic Technologies Ltd. v. [read post]
31 Mar 2015, 9:59 pm
Noonan -- Earlier this month, the Federal Circuit affirmed a District Court judgment of obviousness in ANDA litigation under the Hatch Waxman Act having a long provenance of earlier litigation, in Senju Pharmaceutical Co., Ltd. v. [read post]
28 Apr 2014, 9:51 pm
Noonan -- The Federal Circuit extended the scope of the judicially created doctrine of obviousness-type double patenting (OTDP) in a split decision rendered in Gilead Sciences Inc. v. [read post]
22 Dec 2019, 9:59 pm
The case involved accused infringement of U.S. [read post]
21 Dec 2020, 9:03 pm
Defendant Maia Pharmaceuticals suffered those consequences recently in Bracco Diagnostics Inc. v. [read post]
25 Oct 2016, 9:28 pm
The case involved U.S. [read post]
30 Jul 2019, 9:58 pm
Falk Pharma GmbH v. [read post]
8 Jun 2020, 9:59 pm
Noonan -- In Amneal Pharmacueticals LLC v. [read post]
17 Feb 2021, 9:09 pm
Noonan -- In a terse, non-precedential opinion, the Federal Circuit affirmed a district court's judgment that Defendants Torrent Pharmaceuticals and Indoco Remedies Ltd. had failed to prove that the claims asserted by Plaintiff/patentee Takeda were obvious, either under the statute or the judicially created doctrine of obviousness-type double patenting, in Takeda Pharmaceutical Co. v. [read post]
6 Sep 2021, 9:59 pm
Bard, Inc. v. [read post]
13 Jan 2020, 9:11 pm
Noonan -- The Supreme Court today entered orders denying certiorari in all five cases having petitions on subject matter eligibility, including Athena Diagnostics, Inc. v. [read post]
13 Apr 2022, 7:40 pm
Noonan -- U.S. patent law grants patent owners the right to grant licenses to their patents in analogy to landlords granting rents to real property as a license to use without obtaining ownership. 35 U.S.C. [read post]
22 Nov 2011, 9:59 pm
Noonan -- Sometimes the U.S. and Europe seem to be on diametrically opposed trajectories when it comes to patent policy. [read post]